Glenmark Pharmaceuticals Inc., USAUsage: Aprepitant is indicated for preventing chemotherapy-induced nausea and vomiting (CINV) in patients aged 12 and older undergoing highly or moderately emetogenic chemotherapy, and for preventing postoperative nausea and vomiting (PONV) in adults. It is not intended for treating established nausea and vomiting.